Compare7 min read

GLOW Blend (BPC-157 + TB-500 + GHK-Cu) vs KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV): Mechanism, Specs & Reported Ranges Compared

Side-by-side comparison of GLOW Blend (BPC-157 + TB-500 + GHK-Cu) and KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) — receptor mechanism, half-life, vial sizes, reconstitution and reported study arms.

By PX1 Research Team · August 4, 2026

GLOW Blend (BPC-157 + TB-500 + GHK-Cu) vs KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) at a glance

	GLOW Blend (BPC-157 + TB-500 + GHK-Cu)	KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV)
Class	tri-peptide research blend	four-peptide research blend
Reported half-life	not well characterized	not well characterized
Vial sizes	70 mg blend vial	80 mg blend vial
Typical reconstitution	70 mg blend + 3 mL bacteriostatic water	80 mg blend + 3 mL bacteriostatic water
Research focus	combined repair + dermal-matrix research	repair plus inflammatory-signalling research

Mechanistic difference

KLOW is GLOW plus KPV — the same repair and dermal-matrix trio with an added inflammatory-signalling tripeptide.

Reported study ranges side by side

GLOW Blend (BPC-157 + TB-500 + GHK-Cu)

Study arm	Reported amount	Cadence
Standard arm	one reconstituted unit	daily in blend models

KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV)

Study arm	Reported amount	Cadence
Standard arm	one reconstituted unit	daily in blend models

Practical handling differences

Both arrive lyophilized and shelf-stable. GLOW Blend (BPC-157 + TB-500 + GHK-Cu) is typically prepared at 70 mg blend + 3 mL bacteriostatic water; KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) at 80 mg blend + 3 mL bacteriostatic water. Where half-lives differ, the literature's dosing cadence differs accordingly — longer-acting molecules are described weekly, shorter-acting ones daily or split.

Which one appears in which research context

GLOW Blend (BPC-157 + TB-500 + GHK-Cu) shows up primarily in combined repair + dermal-matrix research. KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) is used in repair plus inflammatory-signalling research. They are not interchangeable substitutes; the receptor profile, not the marketing category, determines where each is used.

Documentation and sourcing

Both are supplied at ≥99% HPLC purity with lot-level COAs at /coa. Product pages: GLOW Blend (BPC-157 + TB-500 + GHK-Cu) · KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV).

How PX1 documents every lot

Every PX1 lot ships with HPLC purity, LC-MS identity, residual solvent, moisture (Karl Fischer), sterility and endotoxin data. Lot documentation is published at /purity-reports, /endotoxin-reports and /coa. Manufacturing, purification, lyophilization and vial fill happen in U.S. facilities — see /manufacturing-process.

Research use only. PX1 Research supplies compounds for laboratory and in-vitro research. Nothing here is medical advice, a dosing recommendation, or an offer for human or veterinary use. Figures cited are reported from published laboratory literature.

Most-researched PX1 compounds

PX1 Research Team

PX1 Research is a primary US cGMP-compliant peptide manufacturer. Our team handles solid-phase synthesis, HPLC purification, lyophilization and in-house analytical testing — every batch ships with a lot-specific Certificate of Analysis.

See how we manufacture

All PX1 Research products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption.